Skip to main content
Caplight Logo









SelekTx

SelekTx

Private
DublinHealthcare & Life Scienceshttps://selektx.com/

Last Round

Series A

Jan 16, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SelekTx operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Grant round in December 2024.

SelekTx is a biotechnology company that develops a platform for engineering precision biologics to target hard-to-drug disease proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

SelekTx Comparables

Compare SelekTx with similar companies based on industry and business-model similarity.

SelekTx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Skape Bio
84%
Orion Biotechnology
81%
Orbit Discovery
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

SelekTx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 16, 2026
GrantDec 2, 2024
GrantJun 23, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

SelekTx Investors

Notable investors and investment history

SelekTx investors
InvestorRounds
Novo Nordisk FoundationGrant
Enterprise IrelandGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 16, 2026

    $12M round completed.

  • Jun 23, 2024

    Received funding from Enterprise Ireland.

Book a demo to see all signals

For institutional investors. Book with your work email.

SelekTx Filings

Explore SEC and related filing metadata, where available.

SelekTx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about SelekTx's valuation, stock price, and market status.

Is SelekTx a public or private company?

SelekTx is a private company.

What is the current stock price of SelekTx?

SelekTx is a private company, so its shares have no public market price. Caplight tracks SelekTx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is SelekTx worth (valuation)?

Valuation information for SelekTx is not publicly available.

Can I buy SelekTx stock?

SelekTx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was SelekTx's last funding round?

SelekTx's most recent funding round was Series A on January 16, 2026.

Who are the main investors in SelekTx?

Key investors in SelekTx include Novo Nordisk Foundation, Enterprise Ireland.

Will SelekTx IPO soon?

No public IPO plans have been announced for SelekTx.

How can I track SelekTx secondary market activity?

Caplight tracks bids, offers, and trades in SelekTx's shares on secondary markets.

Firmographic Details

HeadquartersDublin
Employee Range3
Year Founded2024
Last FundingJan 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?